Description

Rifamycin Sodium

Rifamycin Sodium is a high-purity, broad-spectrum antibiotic used in pharmaceutical formulations for the treatment of bacterial infections, particularly those caused by gram-positive and certain gram-negative bacteria. It functions by inhibiting bacterial DNA-dependent RNA polymerase, suppressing RNA synthesis, and preventing bacterial proliferation. Rifamycin Sodium
• Is a pharmaceutical-grade antibiotic for oral and parenteral use
• Is effective against a broad spectrum of bacterial pathogens
• Is used in oral tablets, capsules, topical formulations, and parenteral solutions
• Supports treatment of respiratory, gastrointestinal, and skin infections
• Is manufactured under Good Manufacturing Practice (GMP) certified conditions
• Is supplied with complete regulatory documentation including Certificate of Analysis (CoA) and technical data
Rifamycin Sodium is chemically designated as the Sodium salt of Rifamycin derivatives. It appears as an orange to red crystalline powder, highly soluble in water, and stable under controlled conditions suitable for pharmaceutical processing.
In pharmaceutical applications, Rifamycin Sodium is used in:
• Oral and parenteral formulations for systemic bacterial infections
• Topical solutions and creams for dermatological infections
• Combination therapies for complex bacterial infections
• Research and development of antibiotic therapies and drug delivery systems
• Clinical studies targeting respiratory, gastrointestinal, and soft tissue infections
Rifamycin Sodium provides bactericidal activity by inhibiting bacterial RNA polymerase, effectively halting transcription and preventing pathogen replication. Its pharmacological properties allow for targeted antibacterial therapy with predictable efficacy.
CarboMer supplies Rifamycin Sodium with control over assay, purity, residual solvents, and microbial content. The material is suitable for regulated pharmaceutical development and formulation.
The material is packaged in sealed, moisture-resistant, tamper-evident containers. Available in laboratory, pilot, and commercial-scale quantities. Minimum order quantities (MOQ), lead times, and documentation including CoA and SDS are provided upon request.
Each batch is tested for identity (IR, HPLC), assay, water content, residual solvents, heavy metals, and microbial limits. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and full traceability documentation accompany every shipment.
As with all CarboMer antibiotic APIs, Rifamycin Sodium is supported by formulation expertise, regulatory guidance, and secure global supply to ensure safe, effective, and compliant pharmaceutical products.